Literature DB >> 18158015

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma.

Stephen A Boorjian1, Igor Frank, Brant Inman, Christine M Lohse, John C Cheville, Bradley C Leibovich, Michael L Blute.   

Abstract

OBJECTIVES: Angiomyolipoma is a benign renal tumor that has a propensity to grow over time and may cause local complications. Given the benign nature of these lesions, renal-preserving treatments are favored. We evaluated our experience with nephron-sparing surgery for renal angiomyolipoma.
METHODS: We reviewed our institutional nephrectomy registry to identify patients treated with nephron-sparing surgery for renal angiomyolipoma between 1970 and 2004. Patients with a diagnosis of tuberous sclerosis were excluded. Patient demographics, perioperative complications, and postoperative outcomes were recorded.
RESULTS: We identified 58 patients treated with nephron-sparing surgery for sporadic renal angiomyolipoma, including 44 women and 14 men. The median tumor size was 3.9 cm (range, 0.8-12.5 cm). In 7 patients (12%), several ipsilateral angiomyolipomas were resected, whereas 2 patients were treated with nephron-sparing surgery for bilateral angiomyolipomas. The overall early complication rate was 12%, including a urine leak in 3 (5%) patients. At a median postoperative follow-up of 8 years (range, 1-31 years), 2 (3.4%) patients had radiographic evidence of local recurrence, although no patient experienced symptom recurrence. The median preoperative serum creatinine level was 1.0 mg/dL (range, 0.5-3.9 mg/dL), and the median creatinine level at last follow-up was 1.1 mg/dL (range, 0.6-3.6 mg/dL). No patient developed de novo chronic renal insufficiency after nephron-sparing surgery, including 4 patients treated for angiomyolipomas in a solitary kidney.
CONCLUSIONS: Nephron-sparing surgery for sporadic renal angiomyolipomas offers preservation of renal function and is associated with acceptable complication and low local recurrence rates. The results of this study support nephron-sparing surgery for these lesions.

Entities:  

Mesh:

Year:  2007        PMID: 18158015     DOI: 10.1016/j.urology.2007.07.045

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  30 in total

Review 1.  Role of embolization in the treatment of renal masses.

Authors:  David Li; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

2.  Clinical presentation, management, and outcome of patients with incidental renal angiomyolipoma in qatar.

Authors:  Hassan Al-Thani; Ayman El-Menyar; Maryam Al-Sulaiti; Jamela El-Mabrok; Khairi Hajaji; Hesham Elgohary; Ahmed Al-Malki; Abdelhakem Tabeb
Journal:  Oman Med J       Date:  2014-11

3.  Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.

Authors:  Florian Bardin; Olivier Chevallier; Aurélie Bertaut; Emmanuel Delorme; Morgan Moulin; Pierre Pottecher; Lucy Di Marco; Sophie Gehin; Eric Mourey; Luc Cormier; Christiane Mousson; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2017-02

4.  Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis.

Authors:  Michael Staehler; Matthias Sauter; Andreas Helck; Ulrich Linsenmaier; Lutz Weber; Karin Mayer; Michael Fischereder
Journal:  Int Urol Nephrol       Date:  2012-09-28       Impact factor: 2.370

5.  Total nephrectomy with nephron-sparing surgery for a giant bilateral renal angiomyolipoma: A case report.

Authors:  Yihong Zhou; Yuxin Tang; Jin Tang; Fei Deng; Y U Gan; Yingbo Dai
Journal:  Oncol Lett       Date:  2015-07-28       Impact factor: 2.967

Review 6.  Renal artery embolization-indications, technical approaches and outcomes.

Authors:  Arnaud Muller; Olivier Rouvière
Journal:  Nat Rev Nephrol       Date:  2014-12-23       Impact factor: 28.314

7.  A case of angiomyolipoma of the renal sinus.

Authors:  Suguru Shirotake; Ichiro Yoshimura; Takeo Kosaka; Shoji Matsuzaki
Journal:  Clin Exp Nephrol       Date:  2011-08-17       Impact factor: 2.801

8.  Trends of presentation and clinical outcome of treated renal angiomyolipoma.

Authors:  Kyo Chul Koo; Won Tae Kim; Won Sik Ham; Jin Sun Lee; Hee Jeong Ju; Young Deuk Choi
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 9.  Bleeding renal angiomyolipoma presenting as duodenal obstruction.

Authors:  Jeremy Yuen Chun Teoh; Ning Hong Chan; Ho Yuen Cheung; Simon See Ming Hou; Chi-Fai Ng
Journal:  Int Urol Nephrol       Date:  2013-06-18       Impact factor: 2.370

Review 10.  Evidence-based protocol-led management of renal angiomyolipoma: A review of literature.

Authors:  Sophie Vaggers; Patrick Rice; Bhaskar K Somani; Rajan Veeratterapillay; Bhavan P Rai
Journal:  Turk J Urol       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.